This WG will discuss the utility and challenges of artificial intelligence (AI) in operations at the PMDA as cross-sectional issues on PMDA, and exchange opinions with external stakeholders as necessary.
（Activity period：From December, 2025）
Activities
- This WG will explore the possibility of applying AI within PMDA and consider how it can contribute to improving operational efficiency and quality.
- This WG will share each department’s experiences in AI utilization and identify key considerations for its application in business operations.
Related Notification
- Action Plan for the Use of AI in Operations at the PMDA[153KB]
September 26, 2025 Pharmaceuticals and Medical Devices Agency